Navigation Links
BioMS Medical Announces 2008 Year End Results
Date:3/17/2009

MS trials. The data also showed that dirucotide was generally well tolerated. The most common side effects reported were redness and burning sensation at the injection site. No patients withdrew due to adverse events. Eligible patients in this trial are now receiving dirucotide on an un-blinded basis to the end of their 27th month in the trial.

Licensing and Development Agreement with Lilly

On December 17, 2007, BioMS entered into a licensing and development agreement (the "Agreement") granting Lilly exclusive worldwide rights to dirucotide. The transaction closed on January 25, 2008 and BioMS received an upfront payment of US $87 million. In September 2008, BioMS received a development milestone payment of US $10 million as a result of the positive interim analysis from the DSMB for MASESTRO-01. BioMS has the potential to receive future development and sales milestones up to US $400 million and escalating royalties on sales if dirucotide is commercialized.

Not later than sixty (60) days following receipt of the final written report of the results of the MAESTRO-01 trial, Lilly shall notify BioMS in writing whether Lilly will terminate the Agreement or alternatively Lilly shall bear 100% of any and all continuing development costs incurred by Lilly or BioMS for dirucotide.

HYC750 and BioCyDex

On May 9, 2008, BioMS entered into a Royalty and Assignment Agreement with Orcrist Bio. Inc. for HYC750, a technology based on hyaluronic acid that has a number of potential therapeutic uses and is being developed as a treatment for the side effects of chemotherapy. BioMS held an exclusive worldwide license to HYC750 from the University of Alberta. As a result of the Royalty and Assignment Agreement, BioMS terminated its license with the University of Alberta and the University entered into
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BioMS Medical warrant extension
2. BioMS Medical to present at BIO CEO and Investor Conference
3. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
4. BioMS Medical recognized at Scrip Awards 2008
5. BioMS Medical Announces Third Quarter 2008 Results
6. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
7. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
9. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
10. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
11. BioMS Medical to present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 ... addressing multi-drug-resistant organisms (MDROs), announced that initial feasibility ... same-shift bacterial detection and susceptibility testing from positive ... on May 31, 2015 in New Orleans, ... class of molecular diagnostics that can quickly detect ...
(Date:5/29/2015)... Market Publishers Ltd and Shanghai ... partnership agreement for quality market research promotion on ... sell research reports worked out by Chem-Report. , ... upon the agreement: “Chem-Report is a Chinese company ... chemical markets on global and country levels. The ...
(Date:5/29/2015)... , May 29, 2015  Caris Life Sciences® ... studies in which researchers utilized Caris Molecular Intelligence®, ... identify potential therapeutic targets in patients with colorectal ... the programmed cell death protein 1 (PD-1) and ... 1 at the 2015 American Society of Clinical ...
(Date:5/29/2015)... and RESEARCH TRIANGLE PARK, N.C. , ... UTHR ) announced today that Roger Jeffs , Ph.D., ... an overview and update on the company,s business at the ... City . The presentation and the immediately ... 2015, at 11:00 AM Eastern Time, and can be accessed ...
Breaking Biology Technology:Data Highlighting GeneWEAVE’s Smarticles™ Technology to be Presented at the 115th General Meeting of the American Society for Microbiology (asm2015) 2Data Highlighting GeneWEAVE’s Smarticles™ Technology to be Presented at the 115th General Meeting of the American Society for Microbiology (asm2015) 3Market Publishers Ltd and Chem-Report Sign Partnership Agreement 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 3Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 2Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 3Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 4
... Contributed by G.H. Goldman, R. Geremia, M. Van,Montagu, and A. Herrera-Estrella, Laboratorium voor,Genetica, ... Introduction , ... of , a high concentration of ... period of exposure to DNA. However, electroporation could also be useful , ...
... , Mammalian , ... Human, B lymphomas: BJAB,P3HR-1, B95-8, UC729-6 , Human, ... Human epithelial cells , ... Human fibroblast , Human, GCT, fibrous ...
... Brigitte Schauf, and Paul Schulze-Lefert, Max-Planck-Institut,fr Zchtungsforschung, Carl-von-Linn-Weg 10, 50829 Kln, Germany,e-mail: panstrug@mpiz-koeln.mpg.de, ... Abstract , ... of gene transfer to bacteria, yeast, ... we describe the use of the Hepta adaptor for the PDS-1000/He biolistic ...
Cached Biology Technology:Transformation of Filamentous Fungi by High-Voltage Electroporation 2Transformation of Filamentous Fungi by High-Voltage Electroporation 3Transformation of Filamentous Fungi by High-Voltage Electroporation 4Transformation of Filamentous Fungi by High-Voltage Electroporation 5Transformation of Filamentous Fungi by High-Voltage Electroporation 6Transformation of Filamentous Fungi by High-Voltage Electroporation 7Transformation of Filamentous Fungi by High-Voltage Electroporation 8Examples of Electro-Transfected Eukaryotic and Prokaryotic Cells 2Examples of Electro-Transfected Eukaryotic and Prokaryotic Cells 3Examples of Electro-Transfected Eukaryotic and Prokaryotic Cells 4Examples of Electro-Transfected Eukaryotic and Prokaryotic Cells 5Single-Cell Complementation of Barley Mlo Mutants Using a PDS-1000/He Hepta System 2Single-Cell Complementation of Barley Mlo Mutants Using a PDS-1000/He Hepta System 3Single-Cell Complementation of Barley Mlo Mutants Using a PDS-1000/He Hepta System 4Single-Cell Complementation of Barley Mlo Mutants Using a PDS-1000/He Hepta System 5Single-Cell Complementation of Barley Mlo Mutants Using a PDS-1000/He Hepta System 6
(Date:4/27/2015)... -- For more than four decades, AUVSI,s Unmanned Systems ... worldwide event for the unmanned land, sea, and air ... any local, national, or trade news organization interested in ... current applications of unmanned technologies. The conference will explore ... industry, and how it will soon impact the lives ...
(Date:4/20/2015)... DUBAI , April 20, 2015 ... soars   Glenbeigh Records Management (GRM), ... contract with Dubai Islamic Bank. Having built up an impressive ... is now a leading player within the records management sector ... company expects to double is GCC staffbase and employ a ...
(Date:4/13/2015)... , April 13, 2015  higi, a leading ... ways to more fully engage with their communities around ... industry-leading, privacy protected and secure API.  ... enables the most accessible, affordable, and convenient vehicle to ... The API will allow ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... pertaining to science and technology, "talking it out" doesn,t seem ... shows that the more people discuss the risks and benefits ... their viewpoint and the less likely they are to ... the difficulty facing state and federal policy leaders when it ...
... Botanical Garden have described eight new plant species collected in ... eastern slopes of the Andes in northern Bolivia. The new ... published in a recent edition of the Missouri Botanical Garden ... and colleagues from the National Herbarium in La Paz, Bolivia ...
... Nov. 4, 2010 BIO-key International, Inc. (OTC Bulletin ... biometric identification solutions, today announced plans to release third ...  In conjunction with the release, BIO-key has scheduled a ... Internet on Thursday, November 11, 2010 at 10:00 a.m. ...
Cached Biology News:More talk, less agreement: Risk discussion can hurt consensus-building on science/technology 2Missouri Botanical Garden researchers discover 8 new species in Boliva national parks 2BIO-key® Announces Third Quarter 2010 Earnings Release and Conference Call Schedule 2
Performance, mycoplasma, virus, and endotoxin tested...
... 10X BlueJuice Gel Loading ... easy loading and tracking ... agarose or native polyacrylamide ... features higher density sucrose ...
... is the most effective ... PCR products. TOPO TA ... TOPO vectors are supplied ... topoisomerase I. This enables ...
ready-to-use solution...
Biology Products: